Notify me when Trill AB files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc. | Common Shares, no par value | 15.02% | $46,586,790 | $6,000,000 | 7,764,465 | +14.8% | Trill AB | 14 Aug 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|